Circulating tumor DNA in peripheral blood can predict the efficacy of immune-targeted therapy in patients with hepatocellular carcinoma
{{output}}
Background & aims: Hepatocellular carcinoma (HCC) is a highly prevalent and fatal malignancy globally. Accurate prognosis prediction is crucial for developing personalized therapeutic strategies. ... ...
